MENU
CING
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cingulate (CING) Earnings Date & Reports
Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety... Show more
A.I. Advisor
published Earnings
CING is expected to report earnings to rise 6.67% to -47 cents per share on November 12
Q3'26
Est.
$-0.48
Q2'26
Beat
by $0.18
Q1'26
Missed
by $0.47
Q4'25
Est.
$-0.93
Q3'25
Missed
by $0.40
The last earnings report on August 13 showed earnings per share of -44 cents, beating the estimate of -63 cents. With 66.38K shares outstanding, the current market capitalization sits at 61.95M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
1901 West 47th Place
Phone
+1 913 942-2300
Employees
14
Web
https://www.cingulate.com